International Stem Cell Corporation Stock
Equities
ISCO
US4603782016
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.097 USD | +7.78% | 0.00% | +56.45% |
Sales 2022 | 8.18M 11.18M | Sales 2023 | 7.79M 10.65M | Capitalization | 496K 678K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 0.61 x |
Net Debt 2022 | 3.53M 4.83M | Net Debt 2023 | 2.59M 3.54M | EV / Sales 2023 | 0.4 x |
P/E ratio 2022 |
-4.35
x | P/E ratio 2023 |
-3.79
x | Employees | 29 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.91% |
1 day | +7.78% | ||
Current month | -2.51% | ||
1 month | -19.17% | ||
3 months | +7.78% | ||
6 months | -11.82% | ||
Current year | +56.45% |
Managers | Title | Age | Since |
---|---|---|---|
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 08-11-30 |
Russell Kern
DFI | Director of Finance/CFO | 38 | 08-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Kern
DFI | Director of Finance/CFO | 38 | 08-09-30 |
Paul Maier
BRD | Director/Board Member | 76 | 07-06-30 |
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 08-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.097 | +7.78% | 200 |
24-05-06 | 0.09 | -7.22% | 102 |
24-05-03 | 0.097 | -11.01% | 970 |
Delayed Quote OTC Markets, May 09, 2024 at 02:57 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+56.45% | 776K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ISCO Stock